×
<- Back

Insomnia treatment guideline case studies

Speciality Classification
Pharmacists
Location
Online
Delivery
Online
Duration
45 mins
Provider
Pharmaceutical Society of Australia

Insomnia treatment guidelines explained

Why is this important?

The Insomnia treatment guideline was written to inform pharmacists of their responsibilities when supplying modified-release melatonin as a Pharmacist Only medicine (modified-release melatonin is being downscheduled from S4 to S3 effective 1 June 2021).

What is your role as a pharmacist?

Pharmacists need to be aware of treatment options for insomnia and understand when modified-release melatonin might be considered.

Learning Objectives

After completing this activity, pharmacists will be able to:

  • Describe medical and lifestyle factors that can contribute to insomnia.
  • Discuss non-prescription pharmacological treatment options for short-term management of insomnia.
  • Identify when modified-release melatonin may be considered an appropriate treatment option for a patient with insomnia.
  • Explain when a patient with insomnia should be referred for medical review.

For an optimal user experience we recommend Firefox and Chrome browsers. Versions of Internet Explorer earlier than 11 are not supported. Please ensure pop-ups are not blocked in your browser settings before launching.

CPD Credits

Accreditation Code:  CP2103

Group 1:  0.75

Group 2:  1.50

This activity has been accredited for 0.75 hours of Group 1 CPD (or 0.75 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 0.75 hours of Group 2 CPD (or 1.5 CPD credits) upon successful completion of relevant assessment activities.

Delivery
Title
Insomnia treatment guideline case studies
Speciality Classification
Location
Provider Type
Education Provider
Duration
45 mins
CPD Points
Group 1 CPD (or 0.75 CPD credits), Group 2 CPD (or 1.5 CPD credits)
Price
Free
Price Details
Exclusive to Members
Location
Online
Price:
Free
Exclusive to Members
Similar Listings
HealthcareLink